FDA Fellowship - Improvement of Safety and Efficacy of Seasonal and Pandemic Influenza Vaccines

Research Project

You will participate in the ongoing research projects which are related to improvement of the safety and efficacy of influenza and other respiratory virus vaccines through optimized antigen immunogenicity and enhanced vaccine production processes, while analyzing their protective effects against viral infections in animal models.

Learning Objectives

• Receive hands-on experience that complements your educational and professional background
• Gain knowledge in areas related to the agency mission
• Investigate humoral and cellular immune responses following infection and vaccination in small animal models
• Understand antigenic structures, correlates of protection of influenza or SARS-CoV-2 viruses
• Gain experience and expertise in preventing diseases and vaccine development against respiratory viruses and emerging pathogens

Mentor

The mentor for this opportunity is Zhiping Ye (Zhiping.ye@fda.hhs.gov). If you have questions about the nature of the research, please contact the mentor.

Citizenship Requirements

• This opportunity is available to U.S. citizens only and Legal Permanent Residents (LPRs).

Qualifications

• Citizenship: LPR or U.S. Citizen
• Degree: Master's Degree or Doctoral Degree received within the last 60 month(s)
• Discipline(s): Life Health and Medical Sciences (9)

Contact Information

To submit your application, scroll to the bottom of this opportunity and click APPLY.

All documents must be in English or include an official English translation.

If you have questions, send an email to ORISE.FDA.CBER@orau.org. Please include the reference code for this opportunity in your email.

*Applications will be reviewed on a rolling-basis.

FDA Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in White Oak, Maryland

The Center for Biologics Evaluation and Research (CBER) is one Center within the Food and Drug Administration, an Agency within the United States Government's Department of Health and Human Services. CBER's mission is to protect and enhance the public health through the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies.